Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database.

Among patients likely to have NMOSD, low AQP4-IgG testing rates, IST use, frequent MS diagnosis claims, and DMT use highlight the need for a diagnostic algorithm and timely treatment of NMOSD.